| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Abdominal Obesity is Associated with the Number of Colorectal Polyps in Men Butnot in Women
|
Miroslaw, Jarosz
|
|
|
25 |
S2 |
p. ii72
|
artikel
|
| 2 |
Abituzumab Combined with Cetuximab Plus Irinotecan Versus Cetuximab Plus Irinotecan Alone, as Second-Line Treatment for Patients with KRAS Wild-Type Metastatic Colorectal Cancer: The Poseidon Phase I/Randomized Phase II Trial
|
Elez, E.
|
|
|
25 |
S2 |
p. ii107
|
artikel
|
| 3 |
Adjuvant Radiotherapy in Periampullary Carcinomas: Dosimetric Comparison of 3DCRT, IMRT and Rapid ARC Plans
|
Moujhuri, Nandi
|
|
|
25 |
S2 |
p. ii50
|
artikel
|
| 4 |
Adjuvant Regorafenib in Stage IV Colorectal Cancer (CRC) After Curative Treatment of Liver Metastases: A Phase III Randomized, Placebo-Controlled Study (COAST)
|
Eric, Van Cutsem
|
|
|
25 |
S2 |
p. ii97
|
artikel
|
| 5 |
Aflibercept/Folfiri vs Placebo/Folfiri in Metastatic Colorectal Cancer: A Post-Hoc Analysis of Median Overall Survival in Velour from the Retrospectively Assessed Time of Starting First-Line Treatment
|
Josep, Tabernero
|
|
|
25 |
S2 |
p. ii104
|
artikel
|
| 6 |
Ampullary Neuro-Endocrine Tumour: Clinicopathological Features, Treatment and Prognosis
|
Rakesh, Singh
|
|
|
25 |
S2 |
p. ii51
|
artikel
|
| 7 |
Analysing the Outcome and Prognostic Factors of Elderly Patients Treated with Single Agent Versus Combination Regimen as First-Line Chemotherapy for Recurrent or Metastatic Gastric Cancer
|
Sun, D.S.
|
|
|
25 |
S2 |
p. ii12
|
artikel
|
| 8 |
Analysis of a Clinical Pathway for Elective Gastrectomy
|
Don, Min Yong
|
|
|
25 |
S2 |
p. ii34
|
artikel
|
| 9 |
Analysis of Glasgow Prognostic Score(GPS) in KRAS EXON2 Wild Type Patients with Metastatic Colorectal Cancer (MCRC) Treated with Salvage-Line Cetuximab-Based Regimen: HGCSG0901
|
Satoshi, Yuki
|
|
|
25 |
S2 |
p. ii86
|
artikel
|
| 10 |
Analysis of Molecular Alterations for Predicting Clinical Benefit to Cetuximab Plus Chemotherapy in First-Line Metastatic Colorectal Cancer (MCRC)
|
Javier, Sastre
|
|
|
25 |
S2 |
p. ii74
|
artikel
|
| 11 |
Analysis of Sociodemographic Parameters of Esophageal Cancer and its Association with ABO Blood Group
|
Kapoor, A.
|
|
|
25 |
S2 |
p. ii10
|
artikel
|
| 12 |
Angiogenic Markers of Response to Neoadjuvant Therapy and Long-Term Prognosis in Locally Advance Rectal Cancers - a Critical Analysis of Available Data
|
Olivia, Lock
|
|
|
25 |
S2 |
p. ii24
|
artikel
|
| 13 |
An Indirect Treatment Comparison and Cost-Effectiveness Analysis Comparing Folfirinox with Nab-Paclitaxel Plus Gemcitabine for First-Line Treatment for Patients with Metastatic Pancreatic Cancer
|
Hollmann, S.
|
|
|
25 |
S2 |
p. ii11
|
artikel
|
| 14 |
Anorectal Malignant Melanoma – Experience of a Single Portuguese Institution
|
Isalia, Miguel
|
|
|
25 |
S2 |
p. ii59
|
artikel
|
| 15 |
Antitumor Activity of Placenta-Derived Mesenchymal Stem Cells on RAT Colon Cancer Model
|
Halyna, Kuznietsova
|
|
|
25 |
S2 |
p. ii70
|
artikel
|
| 16 |
A Phase I Dose-Escalation and Pharmacokinetic Study of S-1 Plus Nab-Paclitaxel in Patients with Unresectable or Recurrent Gastric Cancer
|
Kenji, Ishido
|
|
|
25 |
S2 |
p. ii25
|
artikel
|
| 17 |
A Phase III Trial of Fluoropyrimidines (FP) Plus Bevacizumab (BEV) vs. Bev Alone, or No Treatment as Maintenance Strategy, Following a Standard Combination of FP, Oxaliplatin (OX), and Bev as First-Line Treatment for Patients with Metastatic Colorectal Cancer (MCRC): AIO KRK 0207
|
Arnold, D.
|
|
|
25 |
S2 |
p. ii116
|
artikel
|
| 18 |
A Phase II Study of Panitumumab Plus Irinotecan for Metastatic Colorectal Cancer Patients with Wild KRAS Exon 2, Resistant to Fluoropyrimidine, Oxaliplatin and Irinotecan in Japanese. (OGSG1001)
|
Taishi, Hata
|
|
|
25 |
S2 |
p. ii89
|
artikel
|
| 19 |
Apoptosis and Anergy of T Cell Induced by Pancreatic Stellate Cells Derived Galectin-1 in Pancreatic Cancer
|
Dong, Tang
|
|
|
25 |
S2 |
p. ii22
|
artikel
|
| 20 |
A Prospective Institutional Study of Chemoradiotherapy with Weekly Docetaxel for Unresectable Locally Advanced Esophageal Carcinoma
|
Mukesh, Singhal
|
|
|
25 |
S2 |
p. ii55
|
artikel
|
| 21 |
AQP1 Expression Predicts Survival in Patients with Colon Cancer
|
Woog, Kang Byung
|
|
|
25 |
S2 |
p. ii73
|
artikel
|
| 22 |
A Randomized, Placebo-Controlled, Phase 2 Study of Efatutazone Maintenance Therapy in Patients with Advanced Colorectal Cancer Who Have Achieved Disease Control Following First-Line Chemotherapy
|
Boucher, E.
|
|
|
25 |
S2 |
p. ii8
|
artikel
|
| 23 |
Are the Benefits of Aspirin in Colorectal Cancer Limited to PIK3CA Mutated Cancers?
|
Langley, R.
|
|
|
25 |
S2 |
p. ii109
|
artikel
|
| 24 |
A Retrospective Analysis of Oxaliplatin, Irinotecan and PK-Adjusted 5-Fluorouracil Within a Neoadjuvant Multidisciplinary Approach in Locally Advanced Pancreatic Cancer (LAPC) Patients
|
Patricia, Martin Romano
|
|
|
25 |
S2 |
p. ii48
|
artikel
|
| 25 |
A Retrospective Analysis of Preoperative Folfox Chemotherapy for Locally Advanced Colon Cancer Patients with Pharmacokinetic-Guided Dose Adjustements of 5-FU: Preliminary Results
|
Fusco, J.P.
|
|
|
25 |
S2 |
p. ii83
|
artikel
|
| 26 |
A Retrospective Study of Liver Stereotactic Ablative Radiotherapy: 21 Months of Follow-Up
|
Samuel, Palumbo
|
|
|
25 |
S2 |
p. ii43
|
artikel
|
| 27 |
A Retrospective Study of the Prognostic Value of Various Pathological and Immunohistochemical Features in Tissue Samples from Patients with Pancreatic Neuroendocrine Neoplasms
|
Nizar, Bawahab
|
|
|
25 |
S2 |
p. ii51
|
artikel
|
| 28 |
A Single Centre Review of Incidence of Venous Thromboembolism (VTE) in Patients Receiving Palliative Chemotherapy for Upper Gastrointestinal Cancers and the Impact on Outcomes
|
Christopher, Jingree
|
|
|
25 |
S2 |
p. ii31
|
artikel
|
| 29 |
Assessment of Morphological Response Contributes to Selection of Candidates for Rescue Liver Resection Among Patients Undergoing Chemotherapy for Initially Unresectable Colorectal Liver Metastasis
|
Koichi, Suzuki
|
|
|
25 |
S2 |
p. ii86
|
artikel
|
| 30 |
Association Between Colorectal Cancer Survival Outcomes and GWAS-Identified Colorectal Cancer Susceptibility Polymorphism in Korean Population
|
Woog, Kang Byung
|
|
|
25 |
S2 |
p. ii67
|
artikel
|
| 31 |
Association Between Radio- and Chemotherapy Responsiveness in Advanced Rectal Cancer: Updated Results of Phase II Study
|
Lucjan, Wyrwicz
|
|
|
25 |
S2 |
p. ii100
|
artikel
|
| 32 |
Association of Thymidylate Synthase Gene Polymorphisms and the Outcome of Adjuvant Therapy in Gastric Cancer
|
Anastasia, Udilova
|
|
|
25 |
S2 |
p. ii14
|
artikel
|
| 33 |
A Subgroup of Metastatic Colorectal Cancer Patients with Very Prolonged Disease Control Under Maintenance Therapy with the TLR-9 Agonist MGN1703
|
Riera-Knorrenschild, J.
|
|
|
25 |
S2 |
p. ii8
|
artikel
|
| 34 |
A Systemic Chemotherapy in Carcinomatosis Metastasis from Gastric Cancer (CMGC)
|
Boudjella, Abdelkader El Hakim
|
|
|
25 |
S2 |
p. ii16
|
artikel
|
| 35 |
A Triple Combination Tailored Therapy (Folfiri-Cetuximab) for Safe Dose Intensification: A Multicenter Phase II Proof-Of-Concept Study.
|
Capitain, O.
|
|
|
25 |
S2 |
p. ii7
|
artikel
|
| 36 |
Author Index
|
|
|
|
25 |
S2 |
p. ii118-ii128
|
artikel
|
| 37 |
AXE Beam: Neo-Adjuvant Triplet Versus Doublet Therapy with Radiation and Total Mesorectal Excision for Locally Advanced Rectal Cancer – A Randomized Phase II Study at the End of Recruitment
|
Chiritescu, G.
|
|
|
25 |
S2 |
p. ii109
|
artikel
|
| 38 |
Benign Mesenchymal Non-Gist Tumors of the Subdiaphragmal Digestive Tract
|
Mihai, Diaconescu
|
|
|
25 |
S2 |
p. ii63
|
artikel
|
| 39 |
Bevacizumab Can Be Infused Safely Over 10 Minutes in Metastatic Colorectal Cancer
|
Tarik, Mahfoud
|
|
|
25 |
S2 |
p. ii69
|
artikel
|
| 40 |
Bevacizumab-Containing Chemotherapy in Elderly Patients with Metastatic Colorectal Cancer
|
Jernej, Benedik
|
|
|
25 |
S2 |
p. ii89
|
artikel
|
| 41 |
Bevacizumab in Combination with Irinotecanand Capecitabine as First-Line Treatment for MCRC – Efficacy and Safety
|
Sasa, Jungic
|
|
|
25 |
S2 |
p. ii68
|
artikel
|
| 42 |
Bevacizumab in Combination with Neoadjuvant Therapy in Elderly Patients with Liver Metastases of Colorectal Cancer-Single Center Experience
|
Marija, Ristic
|
|
|
25 |
S2 |
p. ii92
|
artikel
|
| 43 |
Bevacizumab in Moroccan Patients with Metastatic Colorectal Cancer
|
Mohammed, El Fadli
|
|
|
25 |
S2 |
p. ii64
|
artikel
|
| 44 |
Bevacizumab in the First Line Therapy of Metastatic Colorectal Cancer in Olderpatients, Study Avex in Clinical Practice
|
Lenka, Ostrizkova
|
|
|
25 |
S2 |
p. ii92
|
artikel
|
| 45 |
Bursectomy in Gastric Cancer Surgery I.B. Shchepotin O.O. Kolesnik, A.V. Lukashenko, A.A. Burlaka, M.O. Volk, Y.O. Zhukov Department of Abdominal Surgery, National Cancer Institute, Kyiv, Ukraine
|
Ighor, Shchepotin
|
|
|
25 |
S2 |
p. ii37
|
artikel
|
| 46 |
CALGB/SWOG 80405: Phase III Trial of Irinotecan/5-FU/Leucovorin (FOLFIRI) or Oxaliplatin/5-FU/Leucovorin (MFOLFOX6) with Bevacizumab (BV) or Cetuximab (CET) for Patients (PTS) with KRAS Wild-Type (WT) Untreated Metastatic Adenocarcinoma of the Colon
|
Venook, A.
|
|
|
25 |
S2 |
p. ii112
|
artikel
|
| 47 |
Cardiac Toxicity with Fluoropyrimidines in Colorectal Cancer
|
Esther, Una Cidon
|
|
|
25 |
S2 |
p. ii94
|
artikel
|
| 48 |
CA 19-9 Related Tumor Growth Rate After First Line Chemotherapy of Advanced Pancreatic Cancer
|
Giuseppe, Colloca
|
|
|
25 |
S2 |
p. ii48
|
artikel
|
| 49 |
Cell Cycle Interference Contributes to the Anticancer Synergy Between Radiotherapy and Aurora Kinase Inhibitor VE-465 in Hepatocellular Carcinoma
|
Zhong-Zhe, Lin
|
|
|
25 |
S2 |
p. ii20
|
artikel
|
| 50 |
Cetuximab as Monotherapy in Elderly Patients with Metastatic Colorectal Cancer
|
Esther, Una Cidon
|
|
|
25 |
S2 |
p. ii91
|
artikel
|
| 51 |
Cetuximab Every 2 Weeks with First-Line Chemotherapy in APEC Study Patients with Metastatic Colorectal Cancer Grouped According to EGFR Expression
|
Cheng, A.L.
|
|
|
25 |
S2 |
p. ii5
|
artikel
|
| 52 |
Cetuximab with Irinotecan or Oxaliplatin for 1St-Line Metastatic Colorectal Cancer: Updated Data of Effectiveness in the Erebus Cohort Compared to Pivotal Trials
|
Denis, Smith
|
|
|
25 |
S2 |
p. ii91
|
artikel
|
| 53 |
Challenges in Management of Malignant Ileocecal Ulcers
|
Jay, Toshniwal
|
|
|
25 |
S2 |
p. ii94
|
artikel
|
| 54 |
Characterization of Niemann-Pick Type C2 Protein in Hepatocellular Carcinoma
|
Yi-Jen, Liao
|
|
|
25 |
S2 |
p. ii19
|
artikel
|
| 55 |
Chemotherapy and Target Therapy of Advanced Stomach Cancer
|
Olga, Kuznetsova
|
|
|
25 |
S2 |
p. ii31
|
artikel
|
| 56 |
Choice of Preoperative Radiotherapy in Treatment of Distal T2-3N + /- Rectal Cancer
|
Ighor, Shchepotin
|
|
|
25 |
S2 |
p. ii103
|
artikel
|
| 57 |
Circulating Tumor Cells (CTCS) as Prognostic Biomarker in Patients with Advanced Chemorefractory, Ras Wild-Type Colorectal Cancer (CRC) Treated with Cetuximab or Panitumumab
|
Musella, V.
|
|
|
25 |
S2 |
p. ii9
|
artikel
|
| 58 |
Clinical Advantages of Laparoscopic Colorectal Cancer Surgery for the High Elderly Patients Over 85 Years Old
|
Tomizawa, K.
|
|
|
25 |
S2 |
p. ii10
|
artikel
|
| 59 |
Clinical Investigation of the Bone Metastasis from Digestive Cancer
|
Yuki, Shimizu
|
|
|
25 |
S2 |
p. ii32
|
artikel
|
| 60 |
Clinical Manifestation and Treatment of Gastrointestinal Stromal Tumor with Acute Abdominal Pain
|
Bo, Zhang
|
|
|
25 |
S2 |
p. ii57
|
artikel
|
| 61 |
Clinical Outcomes with First-Line Bevacizumab and Chemotherapy for Patients with Metastatic Colorectal Cancer and a History of Diabetes: Results From the Aries Observational Cohort Study
|
Bendell, J.
|
|
|
25 |
S2 |
p. ii8
|
artikel
|
| 62 |
Clinical Significance of Tumour Regression Grade in Locally-Advanced Rectal Cancer Treated with Preoperative Chemoradiotherapy
|
Alba, Hernandez
|
|
|
25 |
S2 |
p. ii100
|
artikel
|
| 63 |
Clinical Validation of a Novel Multiplex Kit for All RAS Mutations in Colorectal Cancer: Results of Rasket (Ras Key Testing) Prospective Multicenter Study
|
Toshihiro, Kudo
|
|
|
25 |
S2 |
p. ii73
|
artikel
|
| 64 |
Clinico-Epidemiological and Therapeutic Profile of Gastric Cancer: Experience of Oncology Department of Regional Military Hospital of Oran
|
Zohra, Boudinar Fatema
|
|
|
25 |
S2 |
p. ii35
|
artikel
|
| 65 |
Clinicopathological Significance of Expression of Beclin1 and P62 in Gastric Cancer
|
Fei, Gu
|
|
|
25 |
S2 |
p. ii15
|
artikel
|
| 66 |
Colorectal Cancer in Patients Age 40 and Under: A Retrospective Analysis of Database from the Institute of Oncology and Radiology of Serbia
|
Jelena, Spasic
|
|
|
25 |
S2 |
p. ii79
|
artikel
|
| 67 |
Colorectal Cancer Subtyping Consortium (CRCSC) Identifies Consensus of Molecular Subtypes
|
Dienstmann, R.
|
|
|
25 |
S2 |
p. ii115
|
artikel
|
| 68 |
Colorectal Carcinoma in Pediatric Age Group-Epidemiological Paradigm
|
Deepak, Jain
|
|
|
25 |
S2 |
p. ii95
|
artikel
|
| 69 |
Combination of Oxaliplatin + Fluorouracil Compared to Fluoropyrimidine Single Agent in Adjuvant Treatment of Young Patients with Colon Cancer
|
Mohammed, Shahin
|
|
|
25 |
S2 |
p. ii77
|
artikel
|
| 70 |
Combined Administration of 5-Fluorouracil as Well as 2-Oxohexyl Isothiocyanate with Selol Gives Synergistic Toxic Effect on HT -29 Colorectal Cancer Cell Lines
|
Lidia, Śliwka
|
|
|
25 |
S2 |
p. ii70
|
artikel
|
| 71 |
Comparative Study Between Using Antracycline Based and Taxane Based Regimens as First Line Therapy for Advanced and Metastatic Gastric Cancer
|
Abeer, Ibrahium
|
|
|
25 |
S2 |
p. ii32
|
artikel
|
| 72 |
Comparison of a New Multiplexed Multigene Approach with Pyrosequencing in Diagnostic Molecular Biology of Colorectal Cancer (CRC)
|
Giovanna, De Maglio
|
|
|
25 |
S2 |
p. ii74
|
artikel
|
| 73 |
Comparison of Cetuximab and Bevacizumab as First-Line Treatment in KRAS Wild Type Advanced Colorectal Cancer Patients: A Retrospective Analysis
|
Qian, Zhang
|
|
|
25 |
S2 |
p. ii76
|
artikel
|
| 74 |
Comparison of Hepatic Resection and Radiofrequency Ablation for Small Hepatocellular Carcinoma: A Meta-Analysis of 16,103 Patients
|
Qinghua, Xu
|
|
|
25 |
S2 |
p. ii44
|
artikel
|
| 75 |
Comparison of the Average Body Weight and Waist Circumference in Patient with Barrett'S Oesophagus and Patient Without Lesions
|
Miroslaw, Jarosz
|
|
|
25 |
S2 |
p. ii36
|
artikel
|
| 76 |
Computed Tomography Scan and Image Reconstruction Models Affects the Target Volume of Liver Cancer Radiotherapy
|
Yi-Jen, Liao
|
|
|
25 |
S2 |
p. ii43
|
artikel
|
| 77 |
Concur: A Randomized, Double-Blind, Placebo-Controlled Phase 3 Study of Regorafenib Monotherapy in Asian Patients with Previously Treated Metastatic Colorectal Cancer (MCRC)
|
Li, J.
|
|
|
25 |
S2 |
p. ii114
|
artikel
|
| 78 |
Concurrent Oral UFT and Pelvic Irradiation as Neoadjuvant Chemoradiation for Operable Rectal Cancer: A Phase II Study
|
Nivine, Gado
|
|
|
25 |
S2 |
p. ii99
|
artikel
|
| 79 |
Conversion Chemotherapy for Technically Unresectable Colorectal Liver Metastases: A Retrospective, Single-Center Study Comparing Chemotherapy Alone or in Combination with Cetuximab or Bevacizumab
|
Vincenzo, Dadduzio
|
|
|
25 |
S2 |
p. ii92
|
artikel
|
| 80 |
Conversion Gastrectomy After Repeated Intravenous and Intraperitoneal Paclitaxel (PTX) Administration with Oral S-1 for Peritoneal Dissemination of Advanced Gastric Cancer with Malignant Ascites
|
Joji, Kitayama
|
|
|
25 |
S2 |
p. ii37
|
artikel
|
| 81 |
Cost-Effectiveness of Different Chemotherapy Strategies for Patients with Advanced Colorectal Cancer in Brazil: A Publichealth System Perspective
|
Adriana, de Carvalho
|
|
|
25 |
S2 |
p. ii93
|
artikel
|
| 82 |
Cost Effectiveness of Selective Internal Radiation Therapy (SIRT) Using YTTRIUM-90 Resin Microspheres for the Treatment of Patients with Inoperable Colorectal Liver Metastases in Italy
|
Maurizio, Cosimelli
|
|
|
25 |
S2 |
p. ii88
|
artikel
|
| 83 |
Cost Effectiveness of Selective Internal Radiation Therapy (SIRT) Using YTTRIUM-90 Resin Microspheres for the Treatment of Patients with Inoperable Colorectal Liver Metastases in the UK
|
Louren, Bester
|
|
|
25 |
S2 |
p. ii88
|
artikel
|
| 84 |
Costs and Patterns of Gastric Cancer Care in the Us: A Retrospective Analysis of Administrative Claims Data
|
Lisa, Hess
|
|
|
25 |
S2 |
p. ii35
|
artikel
|
| 85 |
Cyclooxygenase-2 (COX-2) Expression in a Cohort of Greek Patients with Colorectal Cancer (CRC)
|
Dimitrios, Tzilves
|
|
|
25 |
S2 |
p. ii75
|
artikel
|
| 86 |
Cytokines, Depression and Anxiety in Colorectal Cancer Patients in Different Stages of the Antitumor Therapy
|
Diego, Miranda
|
|
|
25 |
S2 |
p. ii76
|
artikel
|
| 87 |
Decline in CA19-9 During Chemotherapy Predicts Survival in Four Independent Cohorts of Patients with Inoperable Cholangiocarcinoma.
|
Grunnet, M.
|
|
|
25 |
S2 |
p. ii13
|
artikel
|
| 88 |
Deep Responders Represent a Group with Excellent Survival in Patients with Metastatic Colorectal Cancer (MCRC) Treated with Triplet Chemotherapy Regimens (TCR)
|
Shouki, Bazarbashi
|
|
|
25 |
S2 |
p. ii90
|
artikel
|
| 89 |
De Novo Malignancy After Living Donor Liver Transplantation
|
Masahiro, Shinoda
|
|
|
25 |
S2 |
p. ii58
|
artikel
|
| 90 |
Detection of C-KIT and PDGFRA Mutations in GIST by Next Generation Sequencing
|
Céline, De Rop
|
|
|
25 |
S2 |
p. ii14
|
artikel
|
| 91 |
Detention of Molecular Changes Between Primary Tumor (PT) and Synchronous Resected Liver Metastases (SRLM) in Colo-Rectal Cancer (Crc) Patients After First Line Cetuximab Based Chemotherapy (CT)
|
Daniela, Adua
|
|
|
25 |
S2 |
p. ii69
|
artikel
|
| 92 |
Devine Gastric Exclusion: for a Better Palliation in Pyloric Obstruction
|
Sara, Carvalhal
|
|
|
25 |
S2 |
p. ii39
|
artikel
|
| 93 |
Diagnosis, Staging and Treatment of Cholangiocarcinoma; a Retrospective Analysis of Our Last Decade of Experience
|
Mathieu, Heppell Hebert
|
|
|
25 |
S2 |
p. ii62
|
artikel
|
| 94 |
Dietary Fatty Acids Intake and Colorectal Cancer Risk: The Rotterdam Study
|
Kraja, B.
|
|
|
25 |
S2 |
p. ii110
|
artikel
|
| 95 |
Does Biology and Location Predict Chemotherapy Benefit? Patients with Distal Gastric Cancer Have Superior Outcome with Addition of Taxanes Into Combination Chemotherapy While Proximal and Diffuse Gastric Cancers Don'T
|
Murat, Sedef Ali
|
|
|
25 |
S2 |
p. ii34
|
artikel
|
| 96 |
Does the Number of Lymph Nodes Removed in Extended D-2 Lymphadenectomy for Gastric Cancer Impact on Survival?
|
Antonio, Chiappa
|
|
|
25 |
S2 |
p. ii39
|
artikel
|
| 97 |
Dose-Dense Temozolomide (TMZ) in Patients with Advanced Chemorefractory Colorectal Cancer (CRC) and Mgmt Promoter Methylation
|
Filippo, Pietrantonio
|
|
|
25 |
S2 |
p. ii98
|
artikel
|
| 98 |
Druggable Genetic Dependencies for Molecularly Defined Subgroups of Oesophageal Cancer Identified From High-Throughput Functional Profiling
|
Chong, I.
|
|
|
25 |
S2 |
p. ii11
|
artikel
|
| 99 |
Economic Evaluation and Budget Impact Analysis of S-1 (Tegafur/Gimeracil/Oteracil) in Patients with Advanced Gastric Cancer
|
Matteo, Ruggeri
|
|
|
25 |
S2 |
p. ii16
|
artikel
|
| 100 |
Editorial Board
|
|
|
|
25 |
S2 |
p. ii-iii
|
artikel
|
| 101 |
Effect of MIIP/IIP45 Re-Expression by Gene Transfection on the Invasion and Metastasis of Gastric Carcinoma Cells in Vitro
|
Yi-Wei, Wang
|
|
|
25 |
S2 |
p. ii14
|
artikel
|
| 102 |
Effect on the Proliferation, Invasion and Metastasis of Gastric Cancer Cells Transfected by Metastasis Suppressor Gene Kiss-1 in Vivo
|
XiaoBin, Hu
|
|
|
25 |
S2 |
p. ii16
|
artikel
|
| 103 |
Efficacy and Safety of Bevacizumab + Hepatic Arterial Infusion Chemotherapy of Folfiri for Unresectable Colorectal Liver Metastases
|
Yoshiyuki, Wada
|
|
|
25 |
S2 |
p. ii85
|
artikel
|
| 104 |
Efficacy and Safety of Triweekly Docetaxel, Oxaliplatin, Fluorouracil, and Folinic Acid (DOFF) in Patients with Advanced Gastric or Gastroesophageal Adenocarcinoma
|
Ablavi, Adani-Ife
|
|
|
25 |
S2 |
p. ii25
|
artikel
|
| 105 |
Efficacy of Chemotherapy After Treatment with Regorafenib in Metastatic Colorectal Cancer (MCRC)
|
Ryan, Wilcox
|
|
|
25 |
S2 |
p. ii85
|
artikel
|
| 106 |
Efficacy of Continued Sorafenib Treatment After Radiological Confirmation of Disease Progression in Patients with Advanced Hepatocellular Carcinoma
|
Yoshiyuki, Wada
|
|
|
25 |
S2 |
p. ii42
|
artikel
|
| 107 |
Efficacy of Long-Acting Somatostatin Analogues (SA) in Patients (PTS) with Highly Differentiated Gastroenteropancreatic Neuroendocrine Tumors (GEP NETs)
|
Markovich, Alla
|
|
|
25 |
S2 |
p. ii60
|
artikel
|
| 108 |
Efficacy, Safety and Patient-Reported Outcomes of Oxaliplatin-Based Chemotherapy in Elderly Patients with Colorectal Cancer (CRC): A Post-Hoc Analysis of the Glutox Study
|
Benoit, Samson
|
|
|
25 |
S2 |
p. ii80
|
artikel
|
| 109 |
Electroneurography in Evaluation of Peripheral Neuropathy During Oxaliplatin-Based Chemotherapy for Colorectal Cancer
|
Aneta, Zygulska
|
|
|
25 |
S2 |
p. ii57
|
artikel
|
| 110 |
Endoprosthesis in Cardioesophageal Junction Cancer as a Palliative Care
|
Mansoor, Doschanov
|
|
|
25 |
S2 |
p. ii36
|
artikel
|
| 111 |
Endoscopic Treatment of Early Esophageal Carcinoma: A Prospective Evaluation of 40 Consecutive Cases with Promising Results in Patients with T1B Cancers
|
Krajciova, J.
|
|
|
25 |
S2 |
p. ii10
|
artikel
|
| 112 |
Epidemiology of Rectal Cancer in the Regions of Varna and Dobrich, Bulgaria
|
Daniel, Kostov
|
|
|
25 |
S2 |
p. ii65
|
artikel
|
| 113 |
Evaluating the Learning Curve of Magnetic Resonance Imaging (MRI) as a Predictive Tool in Locally Advanced Rectal Cancer (RC) - a Retrospective 12-Year Experience
|
Niamh, Coleman
|
|
|
25 |
S2 |
p. ii80
|
artikel
|
| 114 |
Evaluation of Bowel Doses in Patients Undergoing Dose Escalated Post Operative Intensity Modulated Radiotherapy in Perimapullary Cancers
|
Amit, Bahl
|
|
|
25 |
S2 |
p. ii48
|
artikel
|
| 115 |
Evaluation of Docetaxel, Cisplatin and Capecitabine (DCX) as Perioperative Chemotherapy for Resectable Gastric and Esophago-Gastric Cancer
|
Marcelo, Garrido
|
|
|
25 |
S2 |
p. ii26
|
artikel
|
| 116 |
Evaluation of Induction Chemotherapy Followed by Preoperative Chemoradiation Using IMRT in Locally Advanced Esophageal Cancer – An Indian Experience
|
Subrata, Saha
|
|
|
25 |
S2 |
p. ii54
|
artikel
|
| 117 |
Evaluation of Patient Characteristics and 5-Years Survival Rate in Patients Operated for Gastric Cancer in Bulgaria
|
Kostadin, Angelov
|
|
|
25 |
S2 |
p. ii18
|
artikel
|
| 118 |
Evaluation of the Effect of Aflibercept (Z) on Os by Timing of 1st Line Disease Progression: A Post-Hoc Analysis of the Velour Trial
|
Edith, Mitchell
|
|
|
25 |
S2 |
p. ii84
|
artikel
|
| 119 |
Expression and Function of Metastasis-Associated C4.4A in Hepatocellular Carcinoma
|
Magdalena, Görtz
|
|
|
25 |
S2 |
p. ii20
|
artikel
|
| 120 |
Expression of Sonic Hedgehog and Smoothened in Metastatic Colorectal Cancer
|
Vicente, Valentí
|
|
|
25 |
S2 |
p. ii75
|
artikel
|
| 121 |
Expression of Vitamin D Receptor in Gallbladder Cancer (GBC), Immunoreactivity Scoring (IRS) and Relation of Serum Vitamin D Levels (SVDL) and Effect of Oral Vitamin D Supplementation with Gemcitabine Chemotherapy
|
Abhinav, Sonkar
|
|
|
25 |
S2 |
p. ii56
|
artikel
|
| 122 |
Extending Targeted Therapy Beyond First-Line (1L) Chemotherapy Backbone: Real-World Treatment Patterns and Outcomes in Patients with Metastatic Colorectal Cancer (MCRC)
|
Sham, Chaudhari
|
|
|
25 |
S2 |
p. ii86
|
artikel
|
| 123 |
Factors Affecting Survival of Patients Who Underwent Surgical Resection of Pulmonary Metastases from Colorectal Cancer
|
Franco, Lumachi
|
|
|
25 |
S2 |
p. ii96
|
artikel
|
| 124 |
Feasibility of Irinotecan Based Chemotherapy as Salvage Regimen in Elderly Patients with Metastatic or Recurrent Gastric Cancer
|
Kyu-Hyoung, Lim
|
|
|
25 |
S2 |
p. ii33
|
artikel
|
| 125 |
Final Results and Biomarker Correlation of a Phase II Study of the MTOR Inhibitor Everolimus in Patients with Pre-Treated Metastatic Esophagus, Gastro-Esophageal Junction and Gastric Adenocarcinoma
|
Zev, Wainberg
|
|
|
25 |
S2 |
p. ii53
|
artikel
|
| 126 |
Five-Year Outcomes of a Phase II Study of Adjuvant Chemotherapy with S-1 Plus Docetaxel for Stage III Gastric Cancer After Curative D2 Gastrectomy
|
Shigeyuki, Tamura
|
|
|
25 |
S2 |
p. ii27
|
artikel
|
| 127 |
Folate Intake and Selected Gastrointestinal Cancers Morbidity in Poland in the Years 1960-2010
|
Miroslaw, Jarosz
|
|
|
25 |
S2 |
p. ii23
|
artikel
|
| 128 |
Folfirinox for Locally Advanced or Metastatic Pancreatic Ductal Adenocarcinoma (PDA); Clinical Outcomes and Prognostic Factors, the Royal Marsden (RM) Experience
|
Yu, Moorcraft Sing
|
|
|
25 |
S2 |
p. ii47
|
artikel
|
| 129 |
Folfirinox in Pancreatic Cancer: the National Cancer Institute of Milan Single Experience
|
Fiorella, Dotti Katia
|
|
|
25 |
S2 |
p. ii50
|
artikel
|
| 130 |
Four-Year Survival Rate After Second Line Conversion Treatment to Hepatic Resection Using Triplet Hepatic Artery Infusion and Intravenous Cetuximab for KRAS WT Unresectable Metastatic Colorectal Cancer (European Trial Optiliv, NCT00852228)
|
Francis, Lévi
|
|
|
25 |
S2 |
p. ii83
|
artikel
|
| 131 |
Frequency of S492R Mutations in the Epidermal Growth Factor Receptor: Analysis of Plasma Dna from Metastatic Colorectal Cancer Patients Treated with Panitumumab or Cetuximab Monotherapy
|
Newhall, K.
|
|
|
25 |
S2 |
p. ii109
|
artikel
|
| 132 |
5-Fu Plus Epirubicin is Superior to Standard 5-FU Plus Cisplatin and Epirubicin in the Neoadjuvant Gastric Cancer Spheroid Model
|
Christian, Ilmberger
|
|
|
25 |
S2 |
p. ii17
|
artikel
|
| 133 |
Gallbladder and Biliary Tract Malignancies – Experience of a Center
|
Andreia, Coelho
|
|
|
25 |
S2 |
p. ii60
|
artikel
|
| 134 |
Gastric Adenocarcinoma: Are There Histological and Epidemiological Differences by Gender?
|
German, Calderillo
|
|
|
25 |
S2 |
p. ii29
|
artikel
|
| 135 |
Gastric Adenocarcinoma in Young Population: Are There Epidemiological Differences?
|
German, Calderillo
|
|
|
25 |
S2 |
p. ii29
|
artikel
|
| 136 |
Gastric Cancer Epidemiology in Norte De Santander, Colombia. 2007-2011
|
Maira, Yepes Castaño
|
|
|
25 |
S2 |
p. ii17
|
artikel
|
| 137 |
Gastric Cancer in Young Adults: Experience from Nepal
|
Bishnu, Kandel
|
|
|
25 |
S2 |
p. ii29
|
artikel
|
| 138 |
Gastric Cancer Risk Screening with Combined Assay for Serum Anti-Helicobacter Pylori IGG Antibody and Pepsinogen Level, So-Called “ABC Method”; Can We Need Imaging Study for Gastric Cancer Screening?
|
Takayuki, Nakamura
|
|
|
25 |
S2 |
p. ii35
|
artikel
|
| 139 |
Gastric Neuroendocrine Tumors: A Single Center Experience
|
Ioannis, Pilpilidis
|
|
|
25 |
S2 |
p. ii59
|
artikel
|
| 140 |
Gastrointestinal Cancers: Epidemiological, Clinical, Histological and Therapeutic Characteristic (210 Cases Treated in the Radiotherapy Department of University Hospital of Hassan II-FES-Morocco Between January 2012 and December 2013)
|
Zahra, Farhane Fatima
|
|
|
25 |
S2 |
p. ii62
|
artikel
|
| 141 |
Gastrointestinal Stromal Tumours in a Cohort of South African Patients
|
Barbara, Robertson
|
|
|
25 |
S2 |
p. ii57
|
artikel
|
| 142 |
Gemcitabine(G)-Erlotinib(E) Versus Gemcitabine-Erlotinib-Capecitabine(C) in the First Line Treatment of Patients with Metastatic Pancreatic Cancer (MPC): Efficacy and Safety Results of a Phase IIB Randomized Study from Spanish TTD Collaborative Group
|
Manuel, Benavides
|
|
|
25 |
S2 |
p. ii49
|
artikel
|
| 143 |
Health Related Quality of Life and Survival in Patients Diagnosed with Hepatocellular Carcinoma and Treated with Transarterial Chemoembolization or Yttrium-90
|
Kathryn, Bress
|
|
|
25 |
S2 |
p. ii43
|
artikel
|
| 144 |
Hepatic Arterial Infusion of Chemotherapy as a Salvage Therapy for Patients with Advanced Hepatocellular Carcinoma
|
Yu-Yun, Shao
|
|
|
25 |
S2 |
p. ii42
|
artikel
|
| 145 |
HER 2/NEU Over-Expression Represents a Prognostic Relevant Drugable Target in Liver Metastases of Colorectal Cancer
|
Melanie, Zoller
|
|
|
25 |
S2 |
p. ii69
|
artikel
|
| 146 |
Hormonal and Genetic Features of Combined Treatment of Locally Advanced Gastric Cancer
|
Xamidulla, Kadirov
|
|
|
25 |
S2 |
p. ii26
|
artikel
|
| 147 |
Hyperthermic Intraperitoneal Chemoperfusion in Combined Treatment of Local-Advanced and Peritoneal Disseminated Gastric Cancer
|
Roman, Yarema
|
|
|
25 |
S2 |
p. ii33
|
artikel
|
| 148 |
Hyperuricemia at Time of Diagnosis is a Poor Prognostic Factor for Patients with Colorectal Cancer: A Pilot Study
|
Ozgur, Tanriverdi
|
|
|
25 |
S2 |
p. ii76
|
artikel
|
| 149 |
Image-Guided Hypofractionated Stereotactic Ablative Radiotherapy for the Liver: The Maastro Experience
|
De Lien, VanVoorde
|
|
|
25 |
S2 |
p. ii61
|
artikel
|
| 150 |
Imatinib Mesylate in Treatment of Advanced GIST – Single Institution Experience
|
Vladimir, Nikolić
|
|
|
25 |
S2 |
p. ii60
|
artikel
|
| 151 |
Immediate and Long-Term Outcome of Esd for Differentiated Intramucosal Gastric Cancer Compared to Surgical Resection
|
Min, Park Sung
|
|
|
25 |
S2 |
p. ii28
|
artikel
|
| 152 |
Immunosuppressive Protein Expression on Tumor and the Presence of Immune Cells Within Tumor Microenvironment in Curatively Resected Gastric Cancer
|
Won, Kim Jin
|
|
|
25 |
S2 |
p. ii23
|
artikel
|
| 153 |
Impact of Age on the Feasibility and Efficacy of Neoadjuvant Chemotherapy in Patients with Locally Advanced Gastroesophageal Cancer: A Retrospective Pooled Analysis of Individual Patient Data
|
Sylvie, Lorenzen
|
|
|
25 |
S2 |
p. ii31
|
artikel
|
| 154 |
Impact of the Radio Chemotherapy in the Control Local of the Cancers Locally Advances of the Rectum
|
Haoui, Messaouda
|
|
|
25 |
S2 |
p. ii102
|
artikel
|
| 155 |
Incidence of Hepatic Resection Among Colorectal Cancer Patients with Liver Metastases
|
Keith, Betts
|
|
|
25 |
S2 |
p. ii71
|
artikel
|
| 156 |
Incidence of Kirsten-Ras Gene Mutation and its Association with Clinical and Pathological Factors in Colorectal Carcinoma: Single Institute Retrospective Experience
|
Vinayak, Maka
|
|
|
25 |
S2 |
p. ii65
|
artikel
|
| 157 |
Incidental Hepatocellular Carcinoma: A Hidden Foe for Liver Transplant Recipients?
|
Renata, Senkerikova
|
|
|
25 |
S2 |
p. ii41
|
artikel
|
| 158 |
Increasing Incidence of Gastric Adenocarcinoma in Young Hispanic Residents of the United States
|
Rebecca, Nelson
|
|
|
25 |
S2 |
p. ii36
|
artikel
|
| 159 |
Independent Radiological Evaluation of Objective Response Early Tumor Shrinkage, and Depth of Response in FIRE-3 (AIO KRK-0306)
|
Heinemann, V.
|
|
|
25 |
S2 |
p. ii117
|
artikel
|
| 160 |
Individualization of Surgical Treatment for Digestive Carcinoma Based on Sentinel Lymph Node Biopsy
|
Nebojsa, Mitrovic
|
|
|
25 |
S2 |
p. ii87
|
artikel
|
| 161 |
Influence of Gender on Clinical, Pathological and Prognostic Characteristics of Rectal Cancer in Morocco: A Single Institution Experience
|
Lamiae, Amaadour
|
|
|
25 |
S2 |
p. ii100
|
artikel
|
| 162 |
Insulin Receptor Activation Confers Resistance to Lapatinib Inhibition in HER2-Positive Gastric Cancer
|
Lian, Liu
|
|
|
25 |
S2 |
p. ii17
|
artikel
|
| 163 |
Integrin Expression in Gastric Cancer Impacting Tumor Progression and Treatment
|
Mareile, Joka
|
|
|
25 |
S2 |
p. ii15
|
artikel
|
| 164 |
Interest of Radiochemotherapy in the Rectal Cancer
|
Haoui, Messaouda
|
|
|
25 |
S2 |
p. ii63
|
artikel
|
| 165 |
International Scientific Communications in the Field of Rectal Cancer Patient'S Quality of Life
|
Daniel, Kostov
|
|
|
25 |
S2 |
p. ii64
|
artikel
|
| 166 |
International Visibility of Research on Intersphincteric Resections for Rectal Cancer
|
Daniel, Kostov
|
|
|
25 |
S2 |
p. ii64
|
artikel
|
| 167 |
Intravenous Versus Oral Fluoropyrimidine: Post Gastrectomy Chemoradiation with Jejunal Interposition Reconstruction
|
Mohamed, Salem
|
|
|
25 |
S2 |
p. ii40
|
artikel
|
| 168 |
Intronic SMAD7 Gene Polymorphisms, RS12953717 and RS4464148, in Association with Risk of Colorectal Cancer
|
Shaghayegh, Derakhshani
|
|
|
25 |
S2 |
p. ii68
|
artikel
|
| 169 |
Is a Complete Remission of Intestinal Metaplasia a Suitable Endpoint in Patients Undergoing Radiofrequency Ablation (RFA)? Long-Term Results of RFA Treatment in 62 Consecutive Patients
|
Jana, Krajciova
|
|
|
25 |
S2 |
p. ii54
|
artikel
|
| 170 |
Isothiocyanates are Chemopreventive Compounds and Reduce the MDR Phenomenon - Study on Normal and Colon Cancer Cells
|
Katarzyna, Lubelska
|
|
|
25 |
S2 |
p. ii71
|
artikel
|
| 171 |
Is There a Trend Toward Lower Participation in Colorectal Cancer Screening Among Certain Populations?
|
Jérôme, Viguier
|
|
|
25 |
S2 |
p. ii72
|
artikel
|
| 172 |
KI 67 as a Marker of Prognosis in Morocco Colorectal Cancer
|
Rajae, Najib
|
|
|
25 |
S2 |
p. ii75
|
artikel
|
| 173 |
KRAS Genotype and the Prevalent C.35 G > A Mutation Affect Significantly Worse Prognosis of Metastatic Colorectal Cancer (MCRC) Patients Fitting for Intensive Fir-B/Fox Triplet Chemotherapy Plus Bevacizumab
|
Gemma, Bruera
|
|
|
25 |
S2 |
p. ii73
|
artikel
|
| 174 |
K-RAS in Metastatic Colorectal Cancer
|
Mourad, Belmadi
|
|
|
25 |
S2 |
p. ii93
|
artikel
|
| 175 |
KRAS Mutations in Colorectal Cancer Patients in Serbia: 5 Years Experience of Central Testing
|
Radmila, Jankovic
|
|
|
25 |
S2 |
p. ii74
|
artikel
|
| 176 |
Kras Mutation Status in Colombian Patients with Colorectal Cancer. Analysis of 1104 Consecutive Cases
|
Rocio, Lopez Panqueva
|
|
|
25 |
S2 |
p. ii67
|
artikel
|
| 177 |
KRAS/NRAS and BRAF Mutations in the 20050181 Study of Panitumumab + FOLFIRI for the 2ND-Line Treatment of Metastatic Colorectal Cancer: Updated Analysis
|
Peeters, M.
|
|
|
25 |
S2 |
p. ii5
|
artikel
|
| 178 |
Lack of Association Between SMAD7 Gene Polymorphism and Risk of Colorectal Cancer in an Iranian Population
|
Zahra, Akbari
|
|
|
25 |
S2 |
p. ii71
|
artikel
|
| 179 |
Liver Metastasis Discovered During Surgery of Rectal Cancer
|
Haoui, Messaouda
|
|
|
25 |
S2 |
p. ii63
|
artikel
|
| 180 |
Local Advanced Esophageal Cancer: Precise Prediction of 5-Year Survival After Combined Esophagogastrectomies
|
Oleg, Kshivets
|
|
|
25 |
S2 |
p. ii56
|
artikel
|
| 181 |
Local Recurrence Rate Following Total Gastrectomy by Transabdominal Approach for Siewert'S Type II Esophagogastric Junction Adenocarcinoma
|
Ramiz, Bayramov
|
|
|
25 |
S2 |
p. ii18
|
artikel
|
| 182 |
Low Dose Capecitabine (XELODA) or Teysuno (TEGAFUR) for Treatment of Gastrointestinal Cancer
|
Albertsson, Maria
|
|
|
25 |
S2 |
p. ii54
|
artikel
|
| 183 |
Lymph Node Involvement in Standard Lymphadenectomy for Resectable Pancreatic Head Adenocarcinoma
|
Daniel, Kostov
|
|
|
25 |
S2 |
p. ii51
|
artikel
|
| 184 |
Magnetic Resonance Diffusion as Predictive Value of Response to Treatment with Chemo-Radiotherapy in Patients with Locally Advanced Rectal Cancer
|
Inmaculada, Gallego Jimenez
|
|
|
25 |
S2 |
p. ii103
|
artikel
|
| 185 |
Maintenance Bevacizumab After Induction Chemotherapy: Systematic Review of Literature and Pooled Analysis of Randomized Clinical Trials
|
Emiliano, Tamburini
|
|
|
25 |
S2 |
p. ii77
|
artikel
|
| 186 |
Malignant Lymphoma Diagnosed from Gastrointestinal Biopsy
|
Kazuhiko, Natori
|
|
|
25 |
S2 |
p. ii24
|
artikel
|
| 187 |
Management of HCC in Elderly Patients: an Italian “In Field” Experience
|
Elena, Dionigi
|
|
|
25 |
S2 |
p. ii42
|
artikel
|
| 188 |
Management of Patients with Colorectal Liver Metastasis Harboring More Than 5 Multiple Tumors
|
Kosuke, Ichida
|
|
|
25 |
S2 |
p. ii91
|
artikel
|
| 189 |
Management of Rectal Cancer in Elderly Patients: The Experience of a Single Institution in Morocco
|
Lamiae, Amaadour
|
|
|
25 |
S2 |
p. ii101
|
artikel
|
| 190 |
Meta-Analysis of Phase II Trials Using Bevacizumab with Standard Fluoropyrimidine Based Neoadjuvant Chemoradiotherapy in Patients with Locally Advanced Rectalcancer
|
Yvonne, Mangan
|
|
|
25 |
S2 |
p. ii101
|
artikel
|
| 191 |
Metastatic Hepatocellular Carcinoma; Clinicopathological Characterization and Survival Analysis
|
Omar, Abdel-Rahman
|
|
|
25 |
S2 |
p. ii19
|
artikel
|
| 192 |
Microrna Expression Analysis in Gastric Cancer Using Clustering Methods Based on Microarray Data
|
Sally, Yepes
|
|
|
25 |
S2 |
p. ii15
|
artikel
|
| 193 |
Minimally Invasive Esophagectomy: The New Paradigm?
|
Hugo, Santos-Sousa
|
|
|
25 |
S2 |
p. ii56
|
artikel
|
| 194 |
Modern Treatment of Rectal Cancer Closes the Gap Between Common Adenocarcinoma and Mucinous Carcinoma
|
Hugen, N.
|
|
|
25 |
S2 |
p. ii111
|
artikel
|
| 195 |
Modified Gastroesophageal Anastomosis in Proximal Gastrectomy
|
Ighor, Shchepotin
|
|
|
25 |
S2 |
p. ii37
|
artikel
|
| 196 |
Most Prevalent Pancreatic Neuroendocrine Tumors in Everyday Clinical Practice
|
Iure, Souza
|
|
|
25 |
S2 |
p. ii22
|
artikel
|
| 197 |
Multicenter Phase II Study of Combination Therapy with Oral S-1 Plus Cisplatin in Elderly Patients with Advanced Gastric Cancer
|
Satoru, Iwasa
|
|
|
25 |
S2 |
p. ii39
|
artikel
|
| 198 |
Multimodality Treatment Approach for Locally Advanced Pancreatic Cancer
|
Bernhard, Pestalozzi
|
|
|
25 |
S2 |
p. ii52
|
artikel
|
| 199 |
Nab-Paclitaxel Plus Gemcitabine Vs Gemcitabine Alone for Patients with Metastatic Pancreatic Cancer: Influence of Primary Pancreatic Tumor Location on Efficacy and Treatment Exposure in the Mpact Phase III Trial
|
Jose, Lopez-Martin
|
|
|
25 |
S2 |
p. ii21
|
artikel
|
| 200 |
NAPOLI-1: Randomized Phase 3 Study of MM-398 (NAL-IRI), with or Without 5-Fluorouracil and Leucovorin, Versus 5-Fluorouracil and Leucovorin, in Metastatic Pancreatic Cancer Progressed on or Following Gemcitabine-Based Therapy
|
Von Hoff, D.
|
|
|
25 |
S2 |
p. ii105
|
artikel
|
| 201 |
2ND-Line Therapies After 1st-Line Therapy with Folfiri in Combination with Cetuximab or Bevacizumab in Patients with KRAS Wild-Type Metastatic Colorectal Cancer (MCRC)-Analysis of the AIO KRK 0306 (FIRE 3)- Trial
|
Modest, D.
|
|
|
25 |
S2 |
p. ii112
|
artikel
|
| 202 |
Neoadjuvant Chemoradiation for Rectal Cancers
|
Charu, Singh
|
|
|
25 |
S2 |
p. ii65
|
artikel
|
| 203 |
Neoadjuvant Chemotherapy Capecitabine and Oxaliplatin (XELOX) Combined with Bevacizumab for High-Risk Localized Rectal Cancer
|
Takeshi, Kato
|
|
|
25 |
S2 |
p. ii99
|
artikel
|
| 204 |
Neoadjuvant Chemotherapy for Stomach Cancer Patients
|
Natalya, Sikorsky
|
|
|
25 |
S2 |
p. ii25
|
artikel
|
| 205 |
Neo-Adjuvant Short Course Radiotherapy (The Tlalpan Regime) in a Combined Modality Treatment for Locally Advanced Rectal Cancer with Risk Factors at the Instituto Nacional De Cancerología (México)
|
Jesus, Zamora Moreno
|
|
|
25 |
S2 |
p. ii103
|
artikel
|
| 206 |
Neoadjuvant Therapy in Indian Patients with Locally Advanced Gall Bladdercancer:
|
Bhawna, Sirohi
|
|
|
25 |
S2 |
p. ii61
|
artikel
|
| 207 |
Neonax: Neoadjuvant Plus Adjuvant or Only Adjuvant Nab-Paclitaxel Plus Gemcitabine for Resectable Pancreatic Cancer: A Phase II Study of the Aio Pancreatic Cancer Group
|
Thomas, Ettrich
|
|
|
25 |
S2 |
p. ii52
|
artikel
|
| 208 |
Neuropathy Post- Oxaliplatin in Indian Patients – No Difference Between Generic and Research Molecule
|
Bhawna, Sirohi
|
|
|
25 |
S2 |
p. ii60
|
artikel
|
| 209 |
Novel Mechanism of Wnt Signalling Activation Mediated by DICKKOPF-1 Methylation in Pancreatic Cancer
|
Qinhong, Xu
|
|
|
25 |
S2 |
p. ii23
|
artikel
|
| 210 |
Ocular Toxicities with Oxaliplatin in Colorectal Cancer
|
Esther, Una Cidon
|
|
|
25 |
S2 |
p. ii84
|
artikel
|
| 211 |
Oesophageal Cancer in Morocco: the Epidemiological Evidence
|
Hinde, Hami
|
|
|
25 |
S2 |
p. ii55
|
artikel
|
| 212 |
Oesophageal Cancer in Niamey: An Analysis of the Niger Cancer Registry Data
|
Salamatou, Mamoudou Garba
|
|
|
25 |
S2 |
p. ii104
|
artikel
|
| 213 |
Oral C-Met Inhibitor MSC2156119J as Monotherapy Versus Sorafenib in First-Line Treatment of Asian Patients with Met-Positive Advanced Hepatocellular Carcinoma and Child-Pugh Class a Liver Function: Phase IB/II, Multicenter, Randomized Trial
|
Ann-Lii, Cheng
|
|
|
25 |
S2 |
p. ii45
|
artikel
|
| 214 |
Ordinary Rectal Adenocarcinoma vs. Primary Rectal Signet-Ring Cell Carcinoma
|
Kaoutar, Loikili
|
|
|
25 |
S2 |
p. ii101
|
artikel
|
| 215 |
Organ Preservation Using Contact Radiotherapy for Early Rectal Cancer: Outcomes of Patients Treated at a Single Centre in the United Kingdom
|
Dhadda, A.
|
|
|
25 |
S2 |
p. ii12
|
artikel
|
| 216 |
Outcome According to Tumor Ras Mutation Status in Crystal Study Patients with Metastatic Colorectal Cancer Randomized to Folfiri with or Without Cetuximab as First-Line Treatment
|
Van Cutsem, E.
|
|
|
25 |
S2 |
p. ii113
|
artikel
|
| 217 |
Outcome According to Tumor Ras Mutation Status in Opus Study Patients with Metastatic Colorectal Cancer Randomized to FOLFOX4 with or Without Cetuximab as First-Line Treatment
|
Bokemeyer, C.
|
|
|
25 |
S2 |
p. ii113
|
artikel
|
| 218 |
Palliative Resection of the Primary Tumour is Associated with Increased Survival in Patients with Synchronous Metastatic Colorectal Cancer: A Nationwide Population-Based Study from the Netherlands
|
't Lam -Boer, J.
|
|
|
25 |
S2 |
p. ii110
|
artikel
|
| 219 |
Panitumumab Plus FOLFOX4 or Panitumumab Plus Folfiri in Subjects with Wild-Type KRAS (EXON 2) Colorectal Cancer and Multiple or Unresectable Liver-Limited Metastases: Data from the Randomized, Phase II Planet Study
|
Abad, A.
|
|
|
25 |
S2 |
p. ii7
|
artikel
|
| 220 |
Patterns of Efficacy, Toxicity and Treatment Discontinuation in Egyptian Hepatocellular Carcinoma (Hcc) Patients Receiving Capecitabine Monotherapy
|
Omar, Abdel-Rahman
|
|
|
25 |
S2 |
p. ii40
|
artikel
|
| 221 |
Patterns of Toxicity and Treatment Discontinuation in Egyptian Hepatocellular Carcinoma (HCC) Patients Receiving Sorafenib Monotherapy
|
Omar, Abdel-Rahman
|
|
|
25 |
S2 |
p. ii40
|
artikel
|
| 222 |
Performance Status Remained the Most Important Prognostic Factor in Pancreas Cancer Patients, Single Center Experience
|
Kaan, Helvacı
|
|
|
25 |
S2 |
p. ii47
|
artikel
|
| 223 |
Perioperative Chemotherapy of Resectable Gastroesophageal Cancer in Elderly Patients: A Retrospective Analysis
|
Catarina, Cardoso
|
|
|
25 |
S2 |
p. ii30
|
artikel
|
| 224 |
Perioperative Chemotherapy with Folfox in Resectable Gastro-Oesophageal Adenocarcinoma: An AGEO Multicentric Retrospective Study
|
Florence, Mary
|
|
|
25 |
S2 |
p. ii27
|
artikel
|
| 225 |
Pharmacokinetics of Sunitinib in Patients with Liver Cirrhosis and Hepatocellular Carcinoma
|
Marco, Biolato
|
|
|
25 |
S2 |
p. ii19
|
artikel
|
| 226 |
Phase 2 Double-Blind, Placebo–Controlled Trial of Dasatinib Added to Gemcitabine for Subjects with Locally-Advanced Pancreatic Cancer (LAPC)
|
Evans, J.
|
|
|
25 |
S2 |
p. ii105
|
artikel
|
| 227 |
Phase II Feasibility Study of Adjuvant S-1 Plus Docetaxel Repeated for 6 Months as Adjuvant Chemotherapy for Stage III Gastric Cancer After Curative D2 Gastrectomy (OGSG 1002)
|
Yutaka, Kimura
|
|
|
25 |
S2 |
p. ii27
|
artikel
|
| 228 |
Phase III Study of Apatinib in Advanced Gastric Cancer: A Randomized, Double-Blind, Placebo-Controlled Trial
|
Li, J.
|
|
|
25 |
S2 |
p. ii117
|
artikel
|
| 229 |
Phase II Study of Single Agent Cetuximab in Kras G13D Mutant Metastatic Colorectal Cancer (MCRC)
|
Schirripa, M.
|
|
|
25 |
S2 |
p. ii6
|
artikel
|
| 230 |
Phase I Study of the Investigational Anti-Guanylyl Cyclase C (GCC) Antibody-Drug Conjugate (ADC) Mln0264 in Adult Patients with Advanced Gastrointestinal Malignancies Expressing GCC
|
Faris, J.E.
|
|
|
25 |
S2 |
p. ii108
|
artikel
|
| 231 |
Phase I Trial of 5-FU, Docetaxel and Nedaplatin Combination Therapy for Metastatic Esophageal Cancer
|
Shinichi, Nishina
|
|
|
25 |
S2 |
p. ii55
|
artikel
|
| 232 |
Postoperative Complications of Transthoracic Esopagectomy
|
Shaikh, Abdul Razaque
|
|
|
25 |
S2 |
p. ii56
|
artikel
|
| 233 |
Post Operative Pain Management in Whipples' Procedure -Epidural Analgesia Versus Intravenous Analgesia
|
Anjana, Ghosh Dastidar
|
|
|
25 |
S2 |
p. ii51
|
artikel
|
| 234 |
Pre-Emptive Low-Dose Doxycycline During Anti-EGFR Treatment: A Phase II Study
|
Lucjan, Wyrwicz
|
|
|
25 |
S2 |
p. ii82
|
artikel
|
| 235 |
Preoperative Chemoradiotherapy and Postoperative Chemotherapy with Capecitabine and Oxaliplatin Vs. Capecitabine Alone in Locally Advanced Rectal Cancer: Disease Free Survival at Interim Analysis
|
Schmoll, H.J.
|
|
|
25 |
S2 |
p. ii111
|
artikel
|
| 236 |
Preoperative Chemoradiotherapy and Postoperative Chemotherapy with 5-Fluorouracil and Oxaliplatin Versus 5-Fluorouracil Alone in Locally Advanced Rectal Cancer: Results of the German CAO/ARO/AIO-04 Randomized Phase III Trial
|
Graeven, U.
|
|
|
25 |
S2 |
p. ii116
|
artikel
|
| 237 |
Preoperative Chemotherapy in Patients with Colorectal Liver Metastasis: Experience of Group of Gastrointestinal Tumours of Rimini
|
Emiliano, Tamburini
|
|
|
25 |
S2 |
p. ii79
|
artikel
|
| 238 |
Preoperative Treatment with Radiochemotherapy for Locally Advanced Gastroesophageal Junction (GEJ) Cancer and Unresectable Locally Advanced Gastric Cancer
|
Irena, Oblak
|
|
|
25 |
S2 |
p. ii29
|
artikel
|
| 239 |
Presentation of Insulinoma in Developing World
|
Manish, Kaushal
|
|
|
25 |
S2 |
p. ii58
|
artikel
|
| 240 |
Prespecified Subgroup Analyses in WJOG4407G Trial, a Randomized Phase III Trial of MFOLFOX6 Plus Bevacizumab Versus Folfiri Plus Bevacizumab in First-Line Treatment for Metastatic Colorectal Cancer
|
Hiroshi, Tamagawa
|
|
|
25 |
S2 |
p. ii78
|
artikel
|
| 241 |
Primary Anorectal Melanoma: Report of 21 Cases and Literature Review
|
Tarik, Mahfoud
|
|
|
25 |
S2 |
p. ii59
|
artikel
|
| 242 |
Primary Gastric Lymphomas: About 216 Cases
|
Maher, Slimane
|
|
|
25 |
S2 |
p. ii18
|
artikel
|
| 243 |
Principles of “Fast-Track Surgery” for Pancreticoduodenectomy
|
Igor, Shchepotin
|
|
|
25 |
S2 |
p. ii50
|
artikel
|
| 244 |
Profile of Carcinoma Head of Pancreas Presenting with Extrahepatic Biliary Obstruction in Indian Population
|
Richa, Sharma
|
|
|
25 |
S2 |
p. ii47
|
artikel
|
| 245 |
Prognosis Model for Overall Survival in Locally Advanced Pancreatic Cancer (LAPC): An Ancillary Study of the Lap 07 Trial
|
Vernerey, D.
|
|
|
25 |
S2 |
p. ii105
|
artikel
|
| 246 |
Prognostic Factors in Colorectal Cancer: Serum LDH Levels Predict Survival in Metastatic Disease
|
Rajae, Najib
|
|
|
25 |
S2 |
p. ii81
|
artikel
|
| 247 |
Prognostic Factors in Elderly Patients with Advanced Pancreatic Cancer Treated with Gemcitabine: A Retrospective Analysis of Multicenter Study
|
Ali, Inal
|
|
|
25 |
S2 |
p. ii46
|
artikel
|
| 248 |
Prognostic Factors in Patients with Advanced Pancreatic Cancer Treated with Gemcitabine Chemotherapy: Clinical Characteristics of Long-Term Survivors
|
Uk, Kim Dong
|
|
|
25 |
S2 |
p. ii46
|
artikel
|
| 249 |
Prognostic Relevance of KRAS Mutation in Colorectal Cancer Patients Without Microsatellite Instability
|
Fatemeh, Khorshidi
|
|
|
25 |
S2 |
p. ii68
|
artikel
|
| 250 |
Prognostic Significance of CEA, CA19-9 and CA72-4 Serum Level Before and After Preoperative Chemotherapy of Esophagogastric Junction Adenocarcinoma
|
Milada, Zemanova
|
|
|
25 |
S2 |
p. ii53
|
artikel
|
| 251 |
Prognostic Value of KRAS Mutations in Stage III Colon Cancer: Post-Hoc Analyses of the Petacc8 Phase III Trial
|
Taieb, J.
|
|
|
25 |
S2 |
p. ii115
|
artikel
|
| 252 |
Prospective Multicenter Phase II Trial of 15-Minute Panitumumab Infusion with Irinotecan in Patients with KRAS Wild-Type Chemo-Refractory Metastatic Colorectal Cancer: The Ship Trial
|
Tetsuya, Hamaguchi
|
|
|
25 |
S2 |
p. ii81
|
artikel
|
| 253 |
Qualitative Analysis of the Employment of Brachytherapy in Neoadjuvant Therapy of Liver Cancer
|
Iure, Souza
|
|
|
25 |
S2 |
p. ii44
|
artikel
|
| 254 |
Rainbow: A Global, Phase 3, Double-Blind Study of Ramucirumab Plus Paclitaxel Versus Placebo Plus Paclitaxel in the Treatment of Gastric Cancer Following Disease Progression: Western Population Subgroup
|
Wilke, H.
|
|
|
25 |
S2 |
p. ii106
|
artikel
|
| 255 |
Rainbow: Global, Phase 3, Randomized, Double-Blind Study of Ramucirumab Plus Paclitaxel vs Placebo Plus Paclitaxel Patients with Previously Treated Gastric or Gastroesophageal Junction Adenocarcinoma – Patient-Reported Outcomes and Performance Status
|
Al-Batran, S.E.
|
|
|
25 |
S2 |
p. ii111
|
artikel
|
| 256 |
Randomized Phase II Study of CPT-11 vs PTX; +/- S1 in Advanced Gastric Cancer Refractory to S1 or S1 + Platinum
|
Masahiro, Goto
|
|
|
25 |
S2 |
p. ii28
|
artikel
|
| 257 |
Real-Life Use of Cetuximab in 1st-Line Treatment of Unresectable Metastatic Colorectal Cancer (MCRC) and Outcomes After Surgical Resection of Metastases: Updated Data from the Erebus Cohort
|
Smith, D.
|
|
|
25 |
S2 |
p. ii6
|
artikel
|
| 258 |
Real-World Treatment Patterns Among Patients with Advanced Gastric Cancer in Taiwan
|
Gebra, Cuyun Carter
|
|
|
25 |
S2 |
p. ii16
|
artikel
|
| 259 |
Rectal Cancer in the Algerian West: Clinical Aspects, Management and Outcomes of a Cohort of 85 Patients Treated at the Department of Radiation Oncology of Chuoran
|
Abdelbaki, Boukerche
|
|
|
25 |
S2 |
p. ii102
|
artikel
|
| 260 |
Rediscovering Kojiro's Classification: The Importance of Small Tumor Evaluation in HCC
|
Martins Aline, M.
|
|
|
25 |
S2 |
p. ii20
|
artikel
|
| 261 |
Relation of Lymph Node Level Assessment on Prognosis After Surgical Resection in Biliary Tract Cancers
|
Joaquina, Martinez-Galán
|
|
|
25 |
S2 |
p. ii58
|
artikel
|
| 262 |
Results After D-2 Resection with Spleen and Distal Pancreas Preserved for Gastric Cancer Treatment
|
Antonio, Chiappa
|
|
|
25 |
S2 |
p. ii39
|
artikel
|
| 263 |
Results from a Phase 2 Study of Ruxolitinib or Placebo with Capecitabine as Second-Line Therapy in Patients with Metastatic Pancreatic Cancer: The Recap Trial
|
Hurwitz, H.
|
|
|
25 |
S2 |
p. ii115
|
artikel
|
| 264 |
Results of a Multicenter, Randomized, Double-Blind, Phase III Study of TAS-102 vs. Placebo, with Best Supportive Care (BSC), in Patients (PTS) with Metastatic Colorectal Cancer (MCRC) Refractory to Standard Therapies (RECOURSE)
|
Yoshino, T.
|
|
|
25 |
S2 |
p. ii114
|
artikel
|
| 265 |
Results of Gastropancreatosplenectomy at Locally Advanced Gastric Cancer
|
Mirjalol, Djuraev
|
|
|
25 |
S2 |
p. ii38
|
artikel
|
| 266 |
Results of Surgical Treatment of Colon Cancer with Implementation of a Multimodal Enhanced Recovery Program
|
Ighor, Shchepotin
|
|
|
25 |
S2 |
p. ii96
|
artikel
|
| 267 |
Rtog 0436: A Phase III Trial of Cisplatin, Paclitaxel and Radiation with or Without Cetuximab in the Nonoperative Treatment of Esophageal Cancer
|
Ilson, D.
|
|
|
25 |
S2 |
p. ii106
|
artikel
|
| 268 |
Safety Analysis of Folfox as Adjuvant Chemotherapy for Stage III Colon Cancer in North Japan Multicenter Phase II Study (NORTH/HGCSG1003)
|
Norihiko, Takahashi
|
|
|
25 |
S2 |
p. ii95
|
artikel
|
| 269 |
Salvage Chemotherapy in Metastatic Colorectal Cancer with Combination of Capecitabine and Mitomycin C
|
Aneta, Zygulska
|
|
|
25 |
S2 |
p. ii85
|
artikel
|
| 270 |
Screening for Colorectal Cancer and the Association of Single Nucleotide Polymorphisms at the GSTM1, CHR8 and FOXO1 Genes
|
Garry, Mahon
|
|
|
25 |
S2 |
p. ii72
|
artikel
|
| 271 |
Selective, Synergic and Additive Interaction Types Between 5-Fluorouracil and 2-Oxohexyl Isothiocyanate After Sequential Treatment in Colon Cancer Cell Lines
|
Małgorzata, Milczarek
|
|
|
25 |
S2 |
p. ii70
|
artikel
|
| 272 |
Serum Albumin (SA) as a Predictor of Response to Chemotherapy in Patients with Locally Advanced (LA) Esophageal Cancer
|
Erika, Ruiz-Garcia
|
|
|
25 |
S2 |
p. ii53
|
artikel
|
| 273 |
Simultaneous Detection of KRAS, NRAS Andbraf Hotspot Mutations on Ion Torrent PGM Platform
|
Céline, De Rop
|
|
|
25 |
S2 |
p. ii67
|
artikel
|
| 274 |
Single Centre Experience of Palliative Chemotherapy for Upper Gastrointestinal Cancer
|
Victoria, Plested
|
|
|
25 |
S2 |
p. ii31
|
artikel
|
| 275 |
Single Institution Results of First- Line Treatment with Bevacizumab Plus Chemotherapy in Metastatic Colorectal Cancer (MCRC)
|
Jaroslava, Barkmanova
|
|
|
25 |
S2 |
p. ii90
|
artikel
|
| 276 |
Sparc Analysis in the Phase III MPACT Trial of NAB-Paclitaxel (Nab-P) Plus Gemcitabine (GEM) vs GEM Alone for Patients with Metastatic Pancreatic Cancer (PC)
|
Hidalgo, M.
|
|
|
25 |
S2 |
p. ii106
|
artikel
|
| 277 |
Standard Clinical Practice of Folfirinox in Advanced/Metastatic Pancreatic Cancer (Pc) Patients: A Canadian Registry
|
Jean, Maroun
|
|
|
25 |
S2 |
p. ii49
|
artikel
|
| 278 |
Still Awaiting That Waiting Be a Validated Affordable Option in Rectal Cancer? Our Watch and Wait Approach Experience in Co-Recto
|
Soledad, Iseas
|
|
|
25 |
S2 |
p. ii99
|
artikel
|
| 279 |
Stomach Cancer in Niger: First Results from the Niger Cancer Registry
|
Salamatou, Mamoudou Garba
|
|
|
25 |
S2 |
p. ii35
|
artikel
|
| 280 |
Subgroup Analyses Based on Liver Metastases and the Number of Metastatic Sites from the Mpact Phase III Trial of Nab-Paclitaxel Plus Gemcitabine Vs Gemcitabine Alone for Metastatic Pancreatic Cancer
|
Colin, Weekes
|
|
|
25 |
S2 |
p. ii21
|
artikel
|
| 281 |
Subgroup Analyses in RAS Mutant, BRAF Mutant and “ALL WT” Metastatic Colorectal Cancer Patients Treated with Folfoxiri Plus Bevacizumab (BEV) or Folfiri Plus BEV in the Tribe Study
|
Cremolini, C.
|
|
|
25 |
S2 |
p. ii107
|
artikel
|
| 282 |
Surgical Ablation of Largeer Hcc by Microwave System with Tissue Permittivity Feedback Control Mechanism
|
Kai-Wen, Huang
|
|
|
25 |
S2 |
p. ii45
|
artikel
|
| 283 |
Surgical Management of Synchronous Colorectal Liver Metastases: Simultaneous Versus Staged Resections I.B. Shchepotin, O.O. Kolesnik, A.V. Lukashenko, A.A. Burlaka, V.V. Primak Department of Abdominal Surgery, National Cancer Institute, Kyiv, Ukrain
|
Ighor, Shchepotin
|
|
|
25 |
S2 |
p. ii89
|
artikel
|
| 284 |
Surgical Resection of Liver Metastases and Survival Outcomes Metastatic Colorectal Cancer (MCRC)
|
Adda, Bounedjar
|
|
|
25 |
S2 |
p. ii84
|
artikel
|
| 285 |
Survival Advantage of Metformin in Patients with Colorectal Cancer and Type II Diabetes Mellitus: The Middle Eastern Perspective
|
Ali, Shamseddine
|
|
|
25 |
S2 |
p. ii83
|
artikel
|
| 286 |
Survival of Patients with Hepatocellular Carcinoma in Northern Greece. the Role of Hbv Infection and the Value of Sorafenib in Intermediate Stage of Disease
|
Georgios, Nalmpantidis
|
|
|
25 |
S2 |
p. ii41
|
artikel
|
| 287 |
Table of Contents
|
|
|
|
25 |
S2 |
p. v
|
artikel
|
| 288 |
Tanshinone IIA Can Inhibit Human Pancreatic Cancer BXPC-3 Cells Through Inducing Endoplasmic Reticulum Stress
|
Cheng, Su Chin
|
|
|
25 |
S2 |
p. ii22
|
artikel
|
| 289 |
The Adjuvant Treatment of Rectal Cáncer in Elderly
|
Julia, Ruiz-Vozmediano
|
|
|
25 |
S2 |
p. ii102
|
artikel
|
| 290 |
The CAIRO4 Study: The Role of Surgery of the Primary Tumour with Few or Absent Symptoms in Patients with Synchronous Unresectable Metastases of Colorectal Cancer: A Randomized Phase III Study
|
Jorine, 't Lam - Boer
|
|
|
25 |
S2 |
p. ii98
|
artikel
|
| 291 |
The Change of Serum HER2 Extra Cellular Domain Concentration Before and After Resection in Operable Gastric Cancer Patients in Japan; Consider Relations with Pathological HER2 Status by IHC and Fish
|
Keisei, Taku
|
|
|
25 |
S2 |
p. ii30
|
artikel
|
| 292 |
The Evaluation of Cellular and Humoral Immunity Characteristics in Gastrointestinal and Hepatocellular Cancers
|
Kürsas, Türkdoğan
|
|
|
25 |
S2 |
p. ii14
|
artikel
|
| 293 |
The First Results of a New Anastomosis Technique, Anastomose Covered by Different Types of Meshes
|
Aybala, Agac Ay
|
|
|
25 |
S2 |
p. ii97
|
artikel
|
| 294 |
The Genetic Background of Pancreatic Cancer: Genes That Might Be Biomarkers or Indicators of Metastasis to the Lung
|
Panagiotis, Apostolou
|
|
|
25 |
S2 |
p. ii20
|
artikel
|
| 295 |
The Impact of Folfirinox Chemotherapy on the Treatment Pattern of Patients with Pancreas Cancer Seen at a Tertiary Referral Centre in the UK
|
Neha, Chopra
|
|
|
25 |
S2 |
p. ii45
|
artikel
|
| 296 |
The Initial Institutional Experience About Therapeutic Effect of Un-Cooled Single-Antenna Microwave Ablation for Large Liver Cancers
|
Kai-Wen, Huang
|
|
|
25 |
S2 |
p. ii43
|
artikel
|
| 297 |
The Levels of Methionine Determined Byamino Acid Profiling Correlate with Thedegree of Methylation in Colon Cancertissues
|
Yuji, Takayama
|
|
|
25 |
S2 |
p. ii67
|
artikel
|
| 298 |
The management of locally advanced pancreatic cancer: European Society of Digestive Oncology (ESDO) expert discussion and recommendations from the 14th ESMO/World Congress on Gastrointestinal Cancer, Barcelona
|
Seufferlein, T.
|
|
|
25 |
S2 |
p. ii1-ii4
|
artikel
|
| 299 |
The Management of Peritoneal Surface Malignancies at the American University of Beirut Medical Center: Initial Experience
|
Faek, Jamali
|
|
|
25 |
S2 |
p. ii96
|
artikel
|
| 300 |
The Outcome of Preoperative Chemotherapy Followed by Surgery or Upfront Surgery for Resectable Liver Metastases from Colorectal Cancer: A Single Center Experience
|
Il, Choi Sang
|
|
|
25 |
S2 |
p. ii82
|
artikel
|
| 301 |
The Prime Study: Survival Outcomes for Patients with RAS/BRAF Wild-Type Metastatic Colorectal Cancer, by Baseline ECOG Performance Status
|
Marc, Peeters
|
|
|
25 |
S2 |
p. ii87
|
artikel
|
| 302 |
The Prime Study: Survival Outcomes in Patients with KRAS/NRAS Wild-Type Metastatic Colorectal Cancer and Non-Liver-Limited Disease
|
Douillard, J.Y.
|
|
|
25 |
S2 |
p. ii6
|
artikel
|
| 303 |
The Provision of a Pre-Operative Immunomodulating Diet in Patients Undergoing Radical Resection for Upper Gastrointestinal Cancers Does not Reduce the Risk of Post-Operative Chest Infection
|
Petra, Goldsmith
|
|
|
25 |
S2 |
p. ii62
|
artikel
|
| 304 |
The Randomized Phase 3 Impala Study: Immunomodulatory Maintenance Therapy with TLR-9 Agonist MGN1703 in Patients with Metastatic Colorectal Carcinoma
|
David, Cunningham
|
|
|
25 |
S2 |
p. ii98
|
artikel
|
| 305 |
The Risk Factors of External Intraperitoneal Drainage After Gastrectomy for Gastric Cancer in Patients Without Intra-Operative Drain Tube
|
Janghee, Lee
|
|
|
25 |
S2 |
p. ii38
|
artikel
|
| 306 |
The Role of Choi Criteria in Assessing Response to Tyrosine Kinase Inhibitors (TKIS) in Patients with Advanced Hepatocellular Carcinoma (HCC)
|
Fiona, McCarthy
|
|
|
25 |
S2 |
p. ii44
|
artikel
|
| 307 |
The Role of Peripheral Blood Mononuclear Cells in the Selection of the Best Chemotherapeutic Treatment for Advanced Colorectal Cancer Patients
|
Laura, Rava
|
|
|
25 |
S2 |
p. ii94
|
artikel
|
| 308 |
The Sequential Administration of XELOX and XELIRI Was Effective, Feasible and Manageable for Patients with MCRC
|
Taro, Fukui
|
|
|
25 |
S2 |
p. ii82
|
artikel
|
| 309 |
The Surgical Outcomes After Colorectal Stenting as a Bridge to Surgery
|
Sang-Hoon, Han
|
|
|
25 |
S2 |
p. ii96
|
artikel
|
| 310 |
The Use and the Effects of Health Functional Foods Among Gastrointestinal Cancer Patients in Korea
|
Uk, Kim Dong
|
|
|
25 |
S2 |
p. ii61
|
artikel
|
| 311 |
The Usefulness of Argon Plasma Coagulation in the Treatment of Gastric Adenoma Known as a Premalignant Lesion of Stomach Cancer : Compare with the Endoscopic Submucosal Dissection Group
|
Bae, W.K.
|
|
|
25 |
S2 |
p. ii9
|
artikel
|
| 312 |
The Vague Entity of Colorectal Adenocarcinoma with Mucinous Activity: What'S New?
|
Al-Rahman, Foda Abd
|
|
|
25 |
S2 |
p. ii65
|
artikel
|
| 313 |
The Value of Transcription Factor SCRATCH2 in Colorectal Cancer
|
Nikola, Kolev
|
|
|
25 |
S2 |
p. ii63
|
artikel
|
| 314 |
Timing and Regimens of Adjuvant Therapy for Resected Stage II and III Colon Cancer
|
Josiane, Therrien
|
|
|
25 |
S2 |
p. ii81
|
artikel
|
| 315 |
Title Page
|
|
|
|
25 |
S2 |
p. iv
|
artikel
|
| 316 |
Tolerability and Safety of Cytotoxic Chemotherapy in Patients Over 80 with Colorectal Cancer (CRC) at Heart of England NHS Foundation Trust (HEFT)
|
Sonia, Mansukhani
|
|
|
25 |
S2 |
p. ii77
|
artikel
|
| 317 |
Tolerance of Raltitrexed When Replacing a Fluoropyrimidine in Colorectal Cancer
|
Esther, Una Cidon
|
|
|
25 |
S2 |
p. ii93
|
artikel
|
| 318 |
To Select the Therapies in Gastric Carcinoid Tumors
|
Sei, Kurokawa
|
|
|
25 |
S2 |
p. ii58
|
artikel
|
| 319 |
Toxicity Profile and Outcomes of Antiefgr Treatment in Elderly Patients with KRAS Wild-Type Metastatic Colorectal Cancer. Experience of Virgen DE Las Nieves University Hospital
|
Verónica, Conde-Herrero
|
|
|
25 |
S2 |
p. ii88
|
artikel
|
| 320 |
Transient Elastography (FIBROSCAN®) – Predictor of Hepatocellular Carcinoma Prognosis in Patients Referred to Surgical Treatment
|
Iulia, Suceveanu Andra
|
|
|
25 |
S2 |
p. ii40
|
artikel
|
| 321 |
Trastuzumab in HER-2 Positive Advanced Gastric Carcinoma - Long Term Survivors
|
Natalija, Angelovska Petrusevska
|
|
|
25 |
S2 |
p. ii33
|
artikel
|
| 322 |
Treatment of Patients with Advanced Gastric Cancer -Single Center Experience from Tata Memorial Center (Tmc)
|
Bhawna, Sirohi
|
|
|
25 |
S2 |
p. ii32
|
artikel
|
| 323 |
Treatment of Patients with Metastatic Pancreatic Cancer: the Tata Memorial Centre (TMC) Experience
|
Bhawna, Sirohi
|
|
|
25 |
S2 |
p. ii49
|
artikel
|
| 324 |
Treatment Outcome After D2 Dissection in Operable Gastric Cancer – A Retrospective Analysis
|
Shaikat, Gupta
|
|
|
25 |
S2 |
p. ii38
|
artikel
|
| 325 |
Treatment Outcomes of Patients with Extremely Advanced Inoperable Hepatocellular Carcinoma (HCC) After Yttrium-90 Radioembolization
|
Victor, Lee
|
|
|
25 |
S2 |
p. ii41
|
artikel
|
| 326 |
Treatment Patterns and Outcomes of Patients with Gastric Cancer in the Us: A Retrospective Analysis of Electronic Medical Record (EMR) Data
|
Lisa, Hess
|
|
|
25 |
S2 |
p. ii34
|
artikel
|
| 327 |
Treatment Tactics of Colorectal Cancer Complicated by Bowel Obstruction
|
Hrachya, Manukyan
|
|
|
25 |
S2 |
p. ii97
|
artikel
|
| 328 |
Tumor Budding in Colorectal Cancer with Regards to Mismatch Repair Status – Prognostic Value?
|
Karlberg, M.
|
|
|
25 |
S2 |
p. ii11
|
artikel
|
| 329 |
Under Prescription of Target Therapy in First-Line Metastatic Colorectal Cancer in Elderly People: A Cohort Study in a French Center
|
Amaury, Daste
|
|
|
25 |
S2 |
p. ii78
|
artikel
|
| 330 |
Updates in Rare Colorectal Signet Ring Cell Adenocarcinoma
|
Al-Rahman, Foda Abd
|
|
|
25 |
S2 |
p. ii66
|
artikel
|
| 331 |
Use of Aflibercept (ZALTRAP) as Second Line Therapy in Patients with Metastatic Colorectal Cancer in Named Patient Program in India: Preliminary Analysis of Data from Six Centres
|
Bhawna, Sirohi
|
|
|
25 |
S2 |
p. ii90
|
artikel
|
| 332 |
Use of Oxaliplatin-Based Chemotherapy in Patients with Metastatic Colorectal Cancer (MCRC): A Post-Hoc Analysis of the Glutox Study
|
Benoit, Samson
|
|
|
25 |
S2 |
p. ii79
|
artikel
|
| 333 |
Validation Study of a Blood-Based Gene Expression Signature for Colorectal Cancer Detection
|
Xu, Q.
|
|
|
25 |
S2 |
p. ii13
|
artikel
|
| 334 |
Value of KRAS, BRAF and PIK3CA Mutations and Benefits from Systemic Chemotherapy in Colorectal Peritoneal Carcinomatosis
|
Sasaki, Y.
|
|
|
25 |
S2 |
p. ii13
|
artikel
|
| 335 |
Value of Monitoring Cea in Patients with Colon Cancer Receiving Adjuvant Chemotherapy
|
Andrea, Nagy
|
|
|
25 |
S2 |
p. ii75
|
artikel
|
| 336 |
Variations in Practice - a Need for Regular Institutional Reviews and Participation in Clinical Trials
|
Pierre-Yves, McLaughlin
|
|
|
25 |
S2 |
p. ii24
|
artikel
|
| 337 |
Wait & See Policy Following Complete Clinical Response to Chemoradiotherapy in Rectal Cancer, Single Centre Experience
|
Muhammad, Latif
|
|
|
25 |
S2 |
p. ii102
|
artikel
|
| 338 |
Withdrawn
|
|
|
|
25 |
S2 |
p. ii41
|
artikel
|
| 339 |
Withdrawn
|
|
|
|
25 |
S2 |
p. ii50
|
artikel
|
| 340 |
Withdrawn
|
|
|
|
25 |
S2 |
p. ii72
|
artikel
|
Tijdschrift beschrijving